Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema (left eye)
ICD-10 E10.3492 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema (left eye).
E10.3492 refers to a specific condition in which a patient has Type 1 diabetes mellitus accompanied by severe nonproliferative diabetic retinopathy in the left eye, without the presence of macular edema. Type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, resulting from damage to the blood vessels in the retina due to prolonged hyperglycemia. In severe nonproliferative diabetic retinopathy, there are significant changes in the retinal blood vessels, including microaneurysms, intraretinal hemorrhages, and cotton wool spots, but no new blood vessel growth (proliferation) or macular edema. Management of this condition typically involves strict glycemic control, with HbA1c levels ideally maintained below 7% to reduce the risk of further retinal damage. Insulin therapy is often required to achieve these targets, and regular ophthalmologic examinations are crucial for monitoring the progression of retinopathy.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients presenting with uncontrolled diabetes and complications such as retinopathy.
Ensure that all diabetes-related complications are documented and coded accurately.
Comprehensive eye examination reports detailing the presence and severity of diabetic retinopathy.
Routine eye exams for diabetic patients, particularly those with known retinopathy.
Documentation must specify the eye affected and the type of retinopathy.
Used during routine eye exams for diabetic patients.
Complete eye exam report detailing findings.
Ophthalmologists must document the severity of retinopathy.
Specifying the eye affected is crucial for treatment planning and monitoring progression, as diabetic retinopathy can vary significantly between eyes.
